New insulin delivery devices and glycemic outcomes in young patients with type 1 diabetes: a protocol for a systematic review and meta-analysis

BACKGROUND: Optimal type 1 diabetes mellitus (T1D) care requires lifelong appropriate insulin treatment, which can be provided either by multiple daily injections (MDI) of insulin or by continuous subcutaneous insulin infusion (CSII). An increasing number of trials and previous systematic reviews an...

Descripción completa

Detalles Bibliográficos
Autores principales: Dos Santos, Tiago Jeronimo, Donado Campos, Juan de Mata, Fraga Medin, Cristina Alexandra, Argente, Jesús, Rodríguez-Artalejo, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829915/
https://www.ncbi.nlm.nih.gov/pubmed/31685014
http://dx.doi.org/10.1186/s13643-019-1171-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829915/
https://www.ncbi.nlm.nih.gov/pubmed/31685014
http://dx.doi.org/10.1186/s13643-019-1171-9

Ejemplares similares